Endovascular

View the latest content related to this topic

VIVA 2018

No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy

Women were older than men, had smaller blood vessels and longer lesions, as well as lengthier procedures and more device-related adverse events.

L.A. McKeown

November 13, 2018

Slides

See all

Presentation

VIVA 2018

TOBA II 12-Month Data

Presenter: William Gray

November 09, 2018

Presentation

CDM 2018

New Treatments for Peripheral Artery Disease: What Practitioners Need to Know

Presenter: John R. Laird

October 12, 2018

Presentation

CDM 2018

The Hope and Promise of Renal Denervation

Presenter: Michael A.Weber

October 12, 2018

Presentation

CDM 2018

Abdominal and Thoracic Aneurysmal Disease: Best Treated Percutaneously

Presenter: JohnR .Laird

October 12, 2018

Presentation

TCT Abstracts Posters 2018

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

Presenter: Tamon Kato

September 25, 2018

News

See all

News • Interventional

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

By L.A. McKeown

December 07, 2018

News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

By Michael O'Riordan

December 06, 2018

News

NICE Revisits UK Stroke Guidance, Including Thrombectomy

By Caitlin E. Cox

November 30, 2018

News • Interventional

VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

By L.A. McKeown

November 15, 2018

News

VIVA 2018

No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy

By L.A. McKeown

November 13, 2018

TCT 2018

September 21

September 25, 2018

ESC Congress 2018

August 25

August 29, 2018

Videos on This Topic

See all

Video

Long Calcified SFA Chronic Occlusion

September 24, 2018

Advertisement

Endovascular

No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy

Slides

TOBA II 12-Month Data

New Treatments for Peripheral Artery Disease: What Practitioners Need to Know

The Hope and Promise of Renal Denervation

Abdominal and Thoracic Aneurysmal Disease: Best Treated Percutaneously

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

News

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

NICE Revisits UK Stroke Guidance, Including Thrombectomy

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy

More on This Topic

Upcoming Conferences

CTO 2019

Conference Coverage

TCT 2018

ESC Congress 2018

Videos on This Topic

Long Calcified SFA Chronic Occlusion

Advertisement

Advertisement

Endovascular

Slides

News

More on This Topic

Upcoming Conferences

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content